I reckon it's better than 50:50.
the US Fed is tightening but the PBC (People's Bank of China) is easing. Also pharm/drugs companies are increasing investment into products for growth rather than low margin generics.
Ann: Dimerix Receives $8.9M R&D Tax Incentive Rebate, page-14
Add DXB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
34.0¢ |
Change
0.005(1.49%) |
Mkt cap ! $186.8M | |||
| Open | High | Low | Value | Volume |
| 33.5¢ | 35.0¢ | 33.5¢ | $1.543M | 4.480M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 5 | 160288 | 34.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 35.0¢ | 340963 | 8 |
View Market Depth
| Last trade - 16.10pm 16/05/2024 (20 minute delay) ? |
|
|||||
|
Last
34.5¢ |
Change
0.005 ( 1.47 %) |
||||
| Open | High | Low | Volume | ||
| 33.5¢ | 35.0¢ | 33.5¢ | 2483392 | ||
| Last updated 15.58pm 16/05/2024 ? | |||||
| DXB (ASX) Chart |